Allogeneic transplantation from donors other than HLA-identical siblings.
The decade of the 1990s has witnessed impressive advances in the use of alternative donors for allogeneic transplantations. Through funded collaborative, and single-center research efforts, there is great promise that complete and equal access to allogeneic transplantation will be realized. In the next decade, universal donor availability should maximize the patient's chance of overcoming otherwise fatal disease.
Henslee-Downey
P J
PJ
Department of Medicine, University of South Carolina, USA.
Gluckman
E
E
D016026:Bone Marrow Transplantation; D005190:Family; D005312:Fetal Blood; D006648:Histocompatibility; D006650:Histocompatibility Testing; D006801:Humans; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome